MarcSalimBallasMD

PubMed

• 8 citations
  Immunodynamics of explanted human tumors for immuno-oncology
  Agathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, Safae Terrisse, Nicolas Voisin, Charles Bayard, Sébastien Lofek, Damien Drubay, Delphine Bredel, Severine Mou...> ;EMBO Molecular Medicine. 2021 Jan 11
• 36 citations
  Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC.
  Todd M. Bauer, Benjamin Besse, Alex Martinez-Marti, Jose Manuel Trigo, Victor Moreno, Pilar Garrido, Geraldine Ferron-Brady, Yuehui Wu, Jennifer Park, Therese S. Colli...> ;Journal of Thoracic Oncology. 2019 Oct 1
• 29 citations
  A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN
  Takefumi Komiya, Gideon M. Blumenthal, Roopa DeChowdhury, Susan Fioravanti, Marc S. Ballas, John C. Morris, Thomas J. Hornyak, Stephen A. Wank, Stephen M. Hewitt, Bets...> ;The Oncologist. 2019 Dec 1
• 13 citations
  A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.
  Takefumi Komiya, Regan M. Memmott, Gideon M. Blumenthal, Wendy B. Bernstein, Marc S. Ballas, Roopa De Chowdhury, Guinevere Chun, Cody J. Peer, William D. Figg, David J...> ;Translational Lung Cancer Research. 2019 May 13
• 40 citations
  A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung can...
  D. Ross Camidge, Eamon M. Berge, Robert C. Doebele, Marc S Ballas, Thierry Jahan, Missak Haigentz, David Hoffman, James Spicer, Howard West, Pablo Lee, Ling Yang, Adar...> ;Journal of Thoracic Oncology. 2014 Oct 1
• 29 citations
  A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
  Gideon M. Blumenthal, Joell J. Gills, Marc S. Ballas, Wendy B. Bernstein, Takefumi Komiya, Roopa DeChowdhury, Betsy Morrow, Hyejeong Root, Guinevere Chun, Cynthia Hels...> ;Oncotarget. 2014 Sep 8
• 110 citations
  Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas
  Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Marc S. Ballas, Krysten Brown, Annette O. Nusbaum, Tsivia Hochman, Judith D. Goldberg, Kevin M. Koch, John G....> ;Neuro-Oncology. 2012 Sep 1
• 26 citations
  A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California...
  Barbara J. Gitlitz, Denice D. Tsao-Wei, Susan Groshen, Angela M. Davies, Marianna Koczywas, Chandra P. Belani, Athanassios Argiris, Suresh S. Ramalingam, Everett E. Vo...> ;Journal of Thoracic Oncology. 2012 Mar 1
• 40 citations
  Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
  Marc S Ballas, Abraham Chachoua> ;Oncotargets and Therapy. 2011 May 30
• 10 citations
  Novel therapies for non-small cell lung cancer.
  Jessica S. Donington, Chi Wan Koo, Marc S Ballas> ;Journal of Thoracic Imaging. 2011 May 1
• A phase I study of nelfinavir, an FDA approved HIV protease inhibitor, in adults with refractory solid tumors.
  Dennis PA, Blumenthal G, Ballas M, Gardner E, Kawabata S, LoPiccolo J, Helsabeck C, Root H, Figg WD, Bernstein W> ;J. Clin. Oncol.. 2009-05-20
• 15 citations
  PTEN hamartomatous tumor syndromes (PHTS): Rare syndromes with great relevance to common cancers and targeted drug development
  Jaclyn LoPiccolo, Marc S. Ballas, Phillip A. Dennis> ;Critical Reviews in Oncology/hematology. 2007 Sep 1
• 25 citations
  Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma
  Junji Tsurutani, Seth M. Steinberg, Marc S. Ballas, Matthew Robertson, Jaclyn LoPiccolo, Hiroshi Soda, Shigeru Kohno, Valgardur Egilsson, Phillip A. Dennis> ;Lung Cancer. 2007 Jan 1
• Prognostic significance of clinical features and Akt activation in the survival of patients with bronchioloalveolar carcinoma (BAC).
  Ballas MS, Tsurutani J, Steinberg S, Robertson M, Egilsson V, Dennis PA> ;J. Clin. Oncol.. 2006-06-20
• Overestimating the Influence of the 1999 WHO Classification of Lung Tumors on Survival in Bronchioloalveloar Carcinoma
  Junji Tsurutani, Marc S. Ballas, Phillip A. Dennis> ;Journal of Clinical Oncology. 2006 Apr 20
• 2 citations
  Gefitinib for refractory advanced non-small-cell lung cancer.
  Hisashi Moriguchi, Tae-You Kim, Chifumi Sato> ;Lancet. 2006 Jan 28
• A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer.
  Marc S. Ballas, Phillip A. Dennis> ;Cancer Biology & Therapy. 2005 Oct 18
• Gefitinib for refractory advanced non-small-cell lung cancer.
  Tsurutani, J., Ballas, M., Steinberg, S. M., Egilsson, V., Dennis, P. A.> ;Lancet. 2006 Jan 28
• Join now to see all